Pressure Biosciences Inc
Pressure BioSciences, Inc. develops and sells high pressure technology-based instruments, consumables, and services for life sciences and other industries worldwide. The company's products/services are based on Ultra Shear Technology platform, which turns hydrophobic oil-based supplements, therapeutics, and other active ingredients to water-soluble, bioavailable, oil-in-water nano emulsion formul… Read more
Pressure Biosciences Inc (PBIO) - Total Assets
Latest total assets as of June 2024: $6.88 Million USD
Based on the latest financial reports, Pressure Biosciences Inc (PBIO) holds total assets worth $6.88 Million USD as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Pressure Biosciences Inc - Total Assets Trend (2000–2023)
This chart illustrates how Pressure Biosciences Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Pressure Biosciences Inc - Asset Composition Analysis
Current Asset Composition (December 2023)
Pressure Biosciences Inc's total assets of $6.88 Million consist of 72.4% current assets and 27.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 7.7% |
| Accounts Receivable | $151.23K | 14.4% |
| Inventory | $304.91K | 29.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2000–2023)
This chart illustrates how Pressure Biosciences Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Pressure Biosciences Inc's current assets represent 72.4% of total assets in 2023, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 7.7% of total assets in 2023, down from 7.9% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 4.0% in 2000.
- Asset Diversification: The largest asset category is inventory at 29.1% of total assets.
Pressure Biosciences Inc Competitors by Total Assets
Key competitors of Pressure Biosciences Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Pressure Biosciences Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Pressure Biosciences Inc generates 1.88x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Pressure Biosciences Inc is currently not profitable relative to its asset base.
Pressure Biosciences Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.02 | 0.04 | 0.12 |
| Quick Ratio | 0.01 | 0.02 | 0.07 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-42.70 Million | $ -25.49 Million | $ -10.51 Million |
Pressure Biosciences Inc - Advanced Valuation Insights
This section examines the relationship between Pressure Biosciences Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -47.8% |
| Total Assets | $1.05 Million |
| Market Capitalization | $20.48K USD |
Valuation Analysis
Below Book Valuation: The market values Pressure Biosciences Inc's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Pressure Biosciences Inc's assets decreased by 47.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Pressure Biosciences Inc (2000–2023)
The table below shows the annual total assets of Pressure Biosciences Inc from 2000 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | $1.05 Million | -47.77% |
| 2022-12-31 | $2.01 Million | -29.05% |
| 2021-12-31 | $2.83 Million | +23.00% |
| 2020-12-31 | $2.30 Million | +26.80% |
| 2019-12-31 | $1.82 Million | -24.33% |
| 2018-12-31 | $2.40 Million | +11.10% |
| 2017-12-31 | $2.16 Million | +32.87% |
| 2016-12-31 | $1.63 Million | -9.90% |
| 2015-12-31 | $1.80 Million | +3.45% |
| 2014-12-31 | $1.74 Million | +58.09% |
| 2013-12-31 | $1.10 Million | -18.52% |
| 2012-12-31 | $1.35 Million | -30.17% |
| 2011-12-31 | $1.94 Million | -25.16% |
| 2010-12-31 | $2.59 Million | -19.63% |
| 2009-12-31 | $3.22 Million | +12.92% |
| 2008-12-31 | $2.85 Million | -60.65% |
| 2007-12-31 | $7.26 Million | -30.59% |
| 2006-12-31 | $10.45 Million | -28.56% |
| 2005-12-31 | $14.63 Million | -40.72% |
| 2004-12-31 | $24.69 Million | +46.58% |
| 2003-12-31 | $16.84 Million | -15.12% |
| 2002-12-31 | $19.84 Million | -7.34% |
| 2001-12-31 | $21.41 Million | -5.03% |
| 2000-12-31 | $22.55 Million | -- |